This is an open label trial in subjects ≥12 years of age and older with chronic plaque psoriasis and moderate to severe nail psoriasis. Eligible participants …

Chronic Plaque PsoriasisNail Psoriasis

~Estimated

~$10 – $8,750

Modern Research Associates, PLLCNCT07725822

Phase 3

A Multicenter, Open Label Study to Investigate the Safety and Efficacy of Ponesimod in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis

An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis

Moderate-to-severe Chronic Plaque Psoriasis

~Estimated

~$10 – $8,750

Vanda PharmaceuticalsNCT07362017